Acknowledgements
schizophrenia
This study is supported by the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) under the project title “PerMedSchiz: Personalized medical treatment for schizophrenia“ (Funding reference number: 01KU2002), and the Innovation Fund Denmark (Funding reference number: 9088-00002B). The health economic analyses are supported by the Austrian Science Fund (Wissenschaftsfonds, FWF) under the project title “Personalized medicine in schizophrenia (PerMedSchiz)“ (Funding reference number: I 4725-B). The funders have no role in the design and conduct of the study, the collection and management of the data as well as their respective analysis and the preparation or approval of the manuscript.